Published online
doi:10.1084/jem.20072681
The Journal of Experimental Medicine, Vol. 205, No. 1, 7-12
The Rockefeller University Press, 0022-1007 $30.00
© Sekaly
The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
Rafick-Pierre Sekaly
R.-P. Sekaly is at Université de Montréal, CR-CHUM, Institut National de la Santé et de la Recherche Médicale U743, Montréal, Québec H2X1P1, Canada
CORRESPONDENCE R.P.S.: rafick-pierre.sekaly{at}umontreal.ca
ABSTRACT
The world of human immunodeficiency virus (HIV) vaccines has suffered a baffling setback. The first trial of a vaccine designed to elicit strong cellular immunity has shown no protection against infection. More alarmingly, the vaccine appeared to increase the rate of HIV infection in individuals with prior immunity against the adenovirus vector used in the vaccine. A new study in this issue suggests that a different vaccine approach—using a DNA prime/poxvirus boost strategy—induces polyfunctional immune responses to an HIV immunogen. The disappointing results of the recent vaccine trial suggest that a more thorough assessment of vaccine-induced immune responses is urgently needed, and that more emphasis should be placed on primate models before efficacy trials are undertaken.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
Related Article
-
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
- Alexandre Harari, Pierre-Alexandre Bart, Wolfgang Stöhr, Gonzalo Tapia, Miguel Garcia, Emmanuelle Medjitna-Rais, Séverine Burnet, Cristina Cellerai, Otto Erlwein, Tristan Barber, Christiane Moog, Peter Liljestrom, Ralf Wagner, Hans Wolf, Jean-Pierre Kraehenbuhl, Mariano Esteban, Jonathan Heeney, Marie-Joelle Frachette, James Tartaglia, Sheena McCormack, Abdel Babiker, Jonathan Weber, and Giuseppe Pantaleo
J. Exp. Med. 2008 205: 63-77.
[Abstract]
[Full Text]
[PDF]
This article has been cited by other articles:
-
Beishuizen, C. R. L., Kragten, N. A. M., Boon, L., Nolte, M. A., van Lier, R. A. W., van Gisbergen, K. P. J. M.
(2009). Chronic CD70-Driven Costimulation Impairs IgG Responses by Instructing T Cells to Inhibit Germinal Center B Cell Formation through FasL-Fas Interactions. J. Immunol.
183: 6442-6451
[Abstract]
[Full Text]
-
Muratori, C., Ruggiero, E., Sistigu, A., Bona, R., Federico, M.
(2009). Human immunodeficiency virus type 1 (HIV-1) protease inhibitors block cell-to-cell HIV-1 endocytosis in dendritic cells. J. Gen. Virol.
90: 2777-2787
[Abstract]
[Full Text]
-
Beignon, A.-S., Mollier, K., Liard, C., Coutant, F., Munier, S., Riviere, J., Souque, P., Charneau, P.
(2009). Lentiviral Vector-Based Prime/Boost Vaccination against AIDS: Pilot Study Shows Protection against Simian Immunodeficiency Virus SIVmac251 Challenge in Macaques. J. Virol.
83: 10963-10974
[Abstract]
[Full Text]
-
Wallace, G. S., Cheng-Mayer, C., Schito, M. L., Fletcher, P., Miller Jenkins, L. M., Hayashi, R., Neurath, A. R., Appella, E., Shattock, R. J.
(2009). Human Immunodeficiency Virus Type 1 Nucleocapsid Inhibitors Impede trans Infection in Cellular and Explant Models and Protect Nonhuman Primates from Infection. J. Virol.
83: 9175-9182
[Abstract]
[Full Text]
-
Honda, M., Wang, R., Kong, W.-P., Kanekiyo, M., Akahata, W., Xu, L., Matsuo, K., Natarajan, K., Robinson, H., Asher, T. E., Price, D. A., Douek, D. C., Margulies, D. H., Nabel, G. J.
(2009). Different Vaccine Vectors Delivering the Same Antigen Elicit CD8+ T Cell Responses with Distinct Clonotype and Epitope Specificity. J. Immunol.
183: 2425-2434
[Abstract]
[Full Text]
-
Streeck, H., Jolin, J. S., Qi, Y., Yassine-Diab, B., Johnson, R. C., Kwon, D. S., Addo, M. M., Brumme, C., Routy, J.-P., Little, S., Jessen, H. K., Kelleher, A. D., Hecht, F. M., Sekaly, R.-P., Rosenberg, E. S., Walker, B. D., Carrington, M., Altfeld, M.
(2009). Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+ T Cells. J. Virol.
83: 7641-7648
[Abstract]
[Full Text]
-
Geisbert, T. W., Geisbert, J. B., Leung, A., Daddario-DiCaprio, K. M., Hensley, L. E., Grolla, A., Feldmann, H.
(2009). Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus. J. Virol.
83: 7296-7304
[Abstract]
[Full Text]
-
Brainard, D. M., Seung, E., Frahm, N., Cariappa, A., Bailey, C. C., Hart, W. K., Shin, H.-S., Brooks, S. F., Knight, H. L., Eichbaum, Q., Yang, Y.-G., Sykes, M., Walker, B. D., Freeman, G. J., Pillai, S., Westmoreland, S. V., Brander, C., Luster, A. D., Tager, A. M.
(2009). Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice. J. Virol.
83: 7305-7321
[Abstract]
[Full Text]
-
Wilson, N. A., Keele, B. F., Reed, J. S., Piaskowski, S. M., MacNair, C. E., Bett, A. J., Liang, X., Wang, F., Thoryk, E., Heidecker, G. J., Citron, M. P., Huang, L., Lin, J., Vitelli, S., Ahn, C. D., Kaizu, M., Maness, N. J., Reynolds, M. R., Friedrich, T. C., Loffredo, J. T., Rakasz, E. G., Erickson, S., Allison, D. B., Piatak, M. Jr., Lifson, J. D., Shiver, J. W., Casimiro, D. R., Shaw, G. M., Hahn, B. H., Watkins, D. I.
(2009). Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge. J. Virol.
83: 6508-6521
[Abstract]
[Full Text]
-
Engram, J. C., Dunham, R. M., Makedonas, G., Vanderford, T. H., Sumpter, B., Klatt, N. R., Ratcliffe, S. J., Garg, S., Paiardini, M., McQuoid, M., Altman, J. D., Staprans, S. I., Betts, M. R., Garber, D. A., Feinberg, M. B., Silvestri, G.
(2009). Vaccine-Induced, Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduce Virus Replication but Do Not Protect from Simian Immunodeficiency Virus Disease Progression. J. Immunol.
183: 706-717
[Abstract]
[Full Text]
-
Almeida, J. R., Sauce, D., Price, D. A., Papagno, L., Shin, S. Y., Moris, A., Larsen, M., Pancino, G., Douek, D. C., Autran, B., Saez-Cirion, A., Appay, V.
(2009). Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood
113: 6351-6360
[Abstract]
[Full Text]
-
Burwitz, B. J., Pendley, C. J., Greene, J. M., Detmer, A. M., Lhost, J. J., Karl, J. A., Piaskowski, S. M., Rudersdorf, R. A., Wallace, L. T., Bimber, B. N., Loffredo, J. T., Cox, D. G., Bardet, W., Hildebrand, W., Wiseman, R. W., O'Connor, S. L., O'Connor, D. H.
(2009). Mauritian Cynomolgus Macaques Share Two Exceptionally Common Major Histocompatibility Complex Class I Alleles That Restrict Simian Immunodeficiency Virus-Specific CD8+ T Cells. J. Virol.
83: 6011-6019
[Abstract]
[Full Text]
-
Ourmanov, I., Kuwata, T., Goeken, R., Goldstein, S., Iyengar, R., Buckler-White, A., Lafont, B., Hirsch, V. M.
(2009). Improved Survival in Rhesus Macaques Immunized with Modified Vaccinia Virus Ankara Recombinants Expressing Simian Immunodeficiency Virus Envelope Correlates with Reduction in Memory CD4+ T-Cell Loss and Higher Titers of Neutralizing Antibody. J. Virol.
83: 5388-5400
[Abstract]
[Full Text]
-
Mooij, P., Balla-Jhagjhoorsingh, S. S., Beenhakker, N., van Haaften, P., Baak, I., Nieuwenhuis, I. G., Heidari, S., Wolf, H., Frachette, M.-J., Bieler, K., Sheppard, N., Harari, A., Bart, P.-A., Liljestrom, P., Wagner, R., Pantaleo, G., Heeney, J. L.
(2009). Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens. J. Virol.
83: 5881-5889
[Abstract]
[Full Text]
-
Gaufin, T., Gautam, R., Kasheta, M., Ribeiro, R., Ribka, E., Barnes, M., Pattison, M., Tatum, C., MacFarland, J., Montefiori, D., Kaur, A., Pandrea, I., Apetrei, C.
(2009). Limited ability of humoral immune responses in control of viremia during infection with SIVsmmD215 strain. Blood
113: 4250-4261
[Abstract]
[Full Text]
-
Burgers, W. A., Riou, C., Mlotshwa, M., Maenetje, P., de Assis Rosa, D., Brenchley, J., Mlisana, K., Douek, D. C., Koup, R., Roederer, M., de Bruyn, G., Karim, S. A., Williamson, C., Gray, C. M., and the CAPRISA 002 Acute Infection Study Team,
(2009). Association of HIV-Specific and Total CD8+ T Memory Phenotypes in Subtype C HIV-1 Infection with Viral Set Point. J. Immunol.
182: 4751-4761
[Abstract]
[Full Text]
-
Price, D. A., Asher, T. E., Wilson, N. A., Nason, M. C., Brenchley, J. M., Metzler, I. S., Venturi, V., Gostick, E., Chattopadhyay, P. K., Roederer, M., Davenport, M. P., Watkins, D. I., Douek, D. C.
(2009). Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection. JEM
206: 923-936
[Abstract]
[Full Text]
-
Wang, Y. E., Li, B., Carlson, J. M., Streeck, H., Gladden, A. D., Goodman, R., Schneidewind, A., Power, K. A., Toth, I., Frahm, N., Alter, G., Brander, C., Carrington, M., Walker, B. D., Altfeld, M., Heckerman, D., Allen, T. M.
(2009). Protective HLA Class I Alleles That Restrict Acute-Phase CD8+ T-Cell Responses Are Associated with Viral Escape Mutations Located in Highly Conserved Regions of Human Immunodeficiency Virus Type 1. J. Virol.
83: 1845-1855
[Abstract]
[Full Text]
-
Burgers, W. A., Chege, G. K., Muller, T. L., van Harmelen, J. H., Khoury, G., Shephard, E. G., Gray, C. M., Williamson, C., Williamson, A.-L.
(2009). Broad, high-magnitude and multifunctional CD4+ and CD8+ T-cell responses elicited by a DNA and modified vaccinia Ankara vaccine containing human immunodeficiency virus type 1 subtype C genes in baboons. J. Gen. Virol.
90: 468-480
[Abstract]
[Full Text]
-
Boaz, M. J., Hayes, P., Tarragona, T., Seamons, L., Cooper, A., Birungi, J., Kitandwe, P., Semaganda, A., Kaleebu, P., Stevens, G., Anzala, O., Farah, B., Ogola, S., Indangasi, J., Mhlanga, P., Van Eeden, M., Thakar, M., Pujari, A., Mishra, S., Goonetilleke, N., Moore, S., Mahmoud, A., Sathyamoorthy, P., Mahalingam, J., Narayanan, P. R., Ramanathan, V. D., Cox, J. H., Dally, L., Gill, D. K., Gilmour, J.
(2009). Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three Continents. CVI
16: 147-155
[Abstract]
[Full Text]
-
Gaucher, D., Therrien, R., Kettaf, N., Angermann, B. R., Boucher, G., Filali-Mouhim, A., Moser, J. M., Mehta, R. S., Drake, D. R. III, Castro, E., Akondy, R., Rinfret, A., Yassine-Diab, B., Said, E. A., Chouikh, Y., Cameron, M. J., Clum, R., Kelvin, D., Somogyi, R., Greller, L. D., Balderas, R. S., Wilkinson, P., Pantaleo, G., Tartaglia, J., Haddad, E. K., Sekaly, R.-P.
(2008). Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. JEM
205: 3119-3131
[Abstract]
[Full Text]
-
Badr, G., Bedard, N., Abdel-Hakeem, M. S., Trautmann, L., Willems, B., Villeneuve, J.-P., Haddad, E. K., Sekaly, R. P., Bruneau, J., Shoukry, N. H.
(2008). Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T Cells. J. Virol.
82: 10017-10031
[Abstract]
[Full Text]
-
Brumme, Z. L., Brumme, C. J., Carlson, J., Streeck, H., John, M., Eichbaum, Q., Block, B. L., Baker, B., Kadie, C., Markowitz, M., Jessen, H., Kelleher, A. D., Rosenberg, E., Kaldor, J., Yuki, Y., Carrington, M., Allen, T. M., Mallal, S., Altfeld, M., Heckerman, D., Walker, B. D.
(2008). Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection. J. Virol.
82: 9216-9227
[Abstract]
[Full Text]
-
Sridhar, S., Reyes-Sandoval, A., Draper, S. J., Moore, A. C., Gilbert, S. C., Gao, G. P., Wilson, J. M., Hill, A. V. S.
(2008). Single-Dose Protection against Plasmodium berghei by a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron A. J. Virol.
82: 3822-3833
[Abstract]
[Full Text]